SciELO - Scientific Electronic Library Online

 
vol.39 número1Infarto cerebral en mujer joven con la enfermedad por el coronavirus del 2019 y sin factores de riesgo cardiovasculares: reporte de casoEvaluación de síntomas neuropsiquiátricos para la detección temprana de trastorno neurocognoscitivo índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Acta Neurológica Colombiana

versión impresa ISSN 0120-8748versión On-line ISSN 2422-4022

Resumen

GONZALEZ MANRIQUE, Guillermo; MUNOZ, Joe  y  GARCIA BELTRAN, Juan Camilo. Acute treatment of migraine during pregnancy. Acta Neurol Colomb. [online]. 2023, vol.39, n.1, pp.39-50.  Epub 05-Abr-2023. ISSN 0120-8748.  https://doi.org/10.22379/24224022441.

INTRODUCTION:

Migraine is a prevalent and highly disabling condition. Usually during pregnancy there is relief of symptoms, however, sometimes headache cannot improve, and some cases may get worse. Therefore, it is necessary for physicians who work at the emergency department perform a correct diagnosis of this pathology, rule-out other types of headaches and give the best and safest treatment according to gestational age and clinical profile of each patient. This review will address the relationship between migraine and pregnancy, the role of estrogens in the genesis of migraine. Updated information with respect to acute treatment of migraine during this period will be discussed.

METHODS:

A systematic review of the world literature on the relationship between migraine and pregnancy and acute management in this population was carried out, obtaining a total of 83 bibliographic references.

RESULTS:

As an initial management, the use of acetaminophen plus metoclopramide is recommended at any stage of pregnancy. The use of NSAIDs should be avoided from week 20 of gestation. Sumatriptan can be used as a second line in any trimester.

Non-pharmacological management should be provided to all patients.

CONCLUSIONS:

There are currently safe drugs and procedures for the acute management of migraine in pregnant women, however, gestational age should be taken into account before administering them.

Palabras clave : Adverse effects; Estrogens; Migraine; Pregnancy; Treatment (MeSH).

        · resumen en Español     · texto en Español     · Español ( pdf )